(Updated - April 24, 2025 6:43 AM EDT)

Merck (NYSE: MRK) reported Q1 EPS of $2.22, $0.08 better than the analyst estimate of $2.14. Revenue for the quarter came in at $15.53 billion versus the consensus estimate of $15.33 billion.

GUIDANCE:

Merck sees FY2025 EPS of $8.82-$8.97, versus the consensus of $8.94. Merck sees FY2025 revenue of $64.1-65.6 billion, versus the consensus of $65.01 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

Earnings Guidance